Dare Bioscience
DARE
37 hedge funds and large institutions have $30.6M invested in Dare Bioscience in 2016 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 5 closing their positions.
0% more funds holding
Funds holding: 37 → 37 (0)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
10% less capital invested
Capital invested by funds: $33.9M → $30.6M (-$3.31M)
20% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$197K |
| 2 |
Renaissance Technologies
New York
|
+$39.2K |
| 3 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$37.2K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$36.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$29.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.21M |
| 2 |
Wells Fargo
San Francisco,
California
|
-$621K |
| 3 |
NC
Nexthera Capital
New York
|
-$140K |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$80.9K |
| 5 |
ARTA
A.R.T. Advisors
New York
|
-$54K |
DARE Hedge Fund Activity: Q1 2016 in Review
37 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2016, worth a combined $30.6M — down 9.7% from $33.9M a quarter earlier.
Fund positioning in DARE was balanced in Q1 2016: 5 funds opened new positions, 5 closed out, 8 added to existing stakes and 10 trimmed.
The largest buyer was Vanguard Group, adding an estimated $197K. The largest seller was Fidelity Investments, cutting an estimated $1.21M.
- 37 institutional investors held Dare Bioscience (DARE) as of Q1 2016, unchanged from Q4 2015.
- Funds reported $30.6M of Dare Bioscience stock for Q1 2016, down 9.7% quarter-over-quarter.
- 5 funds opened new Dare Bioscience positions in Q1 2016 and 5 closed out, a net change of 0 holders.
- The largest Dare Bioscience buyer in Q1 2016 was Vanguard Group, an estimated $197K added.
- The largest Dare Bioscience seller in Q1 2016 was Fidelity Investments, an estimated $1.21M sold.
Based on aggregated 13F filings for Q1 2016.